FDA Inspection 1051873 — American Red Cross Blood Services
The FDA completed an inspection of American Red Cross Blood Services on March 27, 2018 in Columbia, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 27, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Columbia, MO (United States)